SAMJIN PHARMACEUTICAL

samjin-pharmaceutical-logo

Everyone has the right to a healthy and happy life. But the complex social structures and advanced material civilizations of modern society are bringing forth many new diseases. In order to protect human health from these diseases and to eradicate the root cause of disease, Samjin Pharm is constantly striving to develop excellent medicines by securing excellent human resources and the latest materials and utilizing advanced medical information and technology.

#Website #More

SAMJIN PHARMACEUTICAL

Social Links:

Industry:
Biotechnology Pharmaceutical

Founded:
1968-04-18

Address:
Mapo, Seoul-t'ukpyolsi, South Korea

Country:
South Korea

Website Url:
http://www.samjinpharm.co.kr

Total Employee:
501+

Status:
Active

Contact:
02) 3140-0700

Technology used in webpage:
SPF SSL By Default Font Awesome ASP.NET IIS Sectigo SSL Sectigo Domain SSL IIS 10 Classic ASP SK Broadband


Official Site Inspections

http://www.samjinpharm.co.kr Semrush global rank: 2.61 M Semrush visits lastest month: 6.65 K

  • Host name: 1.232.177.2
  • IP address: 1.232.177.2
  • Location: Seoul South Korea
  • Latitude: 37.5985
  • Longitude: 126.9783
  • Timezone: Asia/Seoul
  • Postal: 02878

Loading ...

More informations about "Samjin Pharmaceutical"

Samjin Pharmaceutical - Crunchbase Company Profile โ€ฆ

Samjin Pharmaceutical is a company that pioneeres a healthy life for human beings with a creative mind and advances for a prosperous future.See details»

Sam Jin Pharmaceutical Co., Ltd. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Sam Jin Pharmaceutical Co., Ltd. of Seoul, Seoul. Get the latest business insights from Dun & โ€ฆSee details»

Sam Jin Pharmaceutical Co., Ltd. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Sam Jin Pharmaceutical Co., Ltd. of Hwaseong, Gyeonggi. Get the latest business insights from Dun & โ€ฆSee details»

Samjin Pharmaceuticals Co., Ltd. (KRX: 005500) Company Profile ...

3 days ago Samjin Pharmaceuticals Co., Ltd. manufactures and sells medicine. It offers medicine in oral, drop, and injecting forms. The company provides over-the-counter medicines, โ€ฆSee details»

Samjin Pharmaceuticals Co., Ltd. Annual Report - fss.or.kr

[email protected]: Form Information. Consolidated Financial Statements. Statement of financial position: Statement of financial position, current/non-current: Statement of โ€ฆSee details»

Samjin Pharmaceutical Company - PitchBook

Dec 3, 2019 Samjin Pharmaceutical Co Ltd is a part of the healthcare sector in Korea. The company functions as a pharmaceutical product manufacturer addressing severe diseases such as osteoporosis, hepatitis, respiratory and โ€ฆSee details»

Samjin Pharmaceutical - Craft

Oct 29, 2024 Samjin Pharmaceutical โ‚ฉ292.13 b in annual revenue in FY 2023. See insights on Samjin Pharmaceutical including office locations, competitors, revenue, financials, executives, โ€ฆSee details»

Samjin Pharmaceutical Co.,Ltd. (South Korea) - EMIS

Jul 4, 2024 The company offers Geworin, Neuracetam and Bamedin platless tablets. Samjin Pharmaceutical Co.,Ltd. is also developing new medicine such as AIDS preventive drug and โ€ฆSee details»

Samjin Pharm - LinkedIn

Samjin Pharm | 380 followers on LinkedIn. Samjin Pharmaceuticals co., LT D. | ์ธ๊ฐ„์ƒ๋ช…์˜ ์กด์—„์„ฑ์„ ๊ธฐ์—…์ •์‹ ์œผ๋กœ 1968๋…„ ์„ค๋ฆฝ๋œ ์‚ผ์ง„์ œ์•ฝ์€, ๊ฑด๊ฐ•ํ•œ ์‚ถ๊ณผ ํ’์š”๋กœ์šด ...See details»

About Samjin Pharmaceutical Co., Ltd.. - CPHI Online

We, Samjin Pharmaceutical Co., Ltd. are striving to develop a drug for a healthy life and fruitful future as one of the leading companies in Korea. ... KR. 2022. On CPHI since. 2. Certificates. 500 - 999 Employees. Compare. Add to favorites โ€ฆSee details»

Samjin Pharamaceutical Co., Ltd., 121, Wausan-ro, Mapo-gu

Presentation - Samjin Pharamaceutical Co., Ltd. Manufacture & Export of The company pioneering a healthy life of people and challenging the prosperous future with mind of creationSee details»

Company Samjin Pharmaceuticals Co., Ltd. - MarketScreener.com

Sep 28, 2011 Samjin Pharmaceuticals co., LTD. is a Korea-based company mainly engaged in the manufacture of pharmaceutical products. The Companyâ s products include antipyretics, โ€ฆSee details»

Samjin Pharmaceutical Co. Ltd. - BioCentury Company Profiles

Jan 30, 2006 Samjin Pharmaceutical Co. Ltd. - BioCentury Company Profiles for the biopharma industrySee details»

Samjin Pharmaceutical Co Ltd Information - RocketReach

Samjinpharm.co.kr; View Similar People. Related Companies Korea Real Estate Investment Trust Co (034830) 7 $215m GI INNOVATION. 36 $12.2m Samil Pharmaceutical Co Ltd. 50 $110.1m โ€ฆSee details»

Samjin Pharm Co. Ltd | Contact Details | Pharmacompass.com

- Poly DL Lactide co Glycolide - Poly L Lactide - Poly lactic acid - Poly-DL-Lactic-co-Glycolic Acid - Polyethylene Glycol 300 - Polyethylene Glycol 3350 - Polyethylene Glycol 400 - Polyethylene โ€ฆSee details»

Samjin Pharmaceutical Co. Ltd. | Insights

Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»

Samjin Pharm - Company Profile - Tracxn

Nov 15, 2024 Samjin Pharm and Mundipharma Korea to co-promote Norspan patchKBR โ€ข Jul 03, 2024 โ€ข Samjin Pharm, Mundipharma Samjin Pharm, signed a contract of acquisition of 5 โ€ฆSee details»

Samjin Pharmaceutical Portfolio Investments, Samjin โ€ฆ

Aug 23, 2024 Samjin Pharm surpasses โ‚ฉ100 million in medicine donations in H1. Aug 23, 2024. ๋‹ซ๊ธฐ Samjin Pharmaceutical said Friday that its cumulative donations of essential medicines to โ€ฆSee details»

SAMJIN HEALTH PHARM CO.,LTD. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for SAMJIN HEALTH PHARM CO.,LTD. of Gwangju, Gwangju. Get the latest business insights from Dun โ€ฆSee details»

Samjin Pharmaceuticals KOSE:A005500 Stock Report - Simply Wall St

Oct 31, 2024 Samjin Pharmaceuticals Co., Ltd. (KOSE:A005500) announces an Equity Buyback for KRW 5,000 million worth of its shares. Jun 05. New major risk - Financial data availability โ€ฆSee details»